시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 단백질 시퀀스 시장 보고서(2025년)
Protein Sequencing Global Market Report 2025
상품코드 : 1825526
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

단백질 시퀀스 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 9.3%로 26억 7,000만 달러로 성장합니다. 예측 기간의 성장은 임상 유전체학의 통합, 농업 유전체학의 확대, 약물 안전성 및 약물유전체학, 산전 및 신생아 선별검사, 환경 DNA 분석에 기인합니다. 예측 기간의 주요 동향으로는 차세대 시퀀서 수요 증가, 임상 진단에 대한 응용 확대, 유전체 연구에 대한 투자 증가, 맞춤형 의료에 대한 활용 확대 등을 들 수 있습니다.

향후 5년간 9.3%의 성장률 전망은 지난번 전망치보다 0.8% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 스웨덴과 영국에서 개발된 질량분석 시약과 차세대 단백질 시퀀서의 가격을 급등시킴으로써 미국의 정밀의료에 대한 노력을 방해하고, 그 결과 질병 프로파일링이 지연되고 유전체 연구 예산이 증가할 수 있습니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

유전성 질환의 유병률 증가는 단백질 시퀀싱 시장의 성장을 가속할 것으로 예측됩니다. 유전병은 개인의 유전물질(일반적으로 DNA)의 이상이나 돌연변이로 인해 발생하는 질병이나 장애를 말합니다. 이러한 돌연변이는 자연적으로 발생하기도 하고, 부모로부터 유전되기도 합니다. 단백질 시퀀싱은 이러한 질병을 유발하는 유전자 돌연변이 확인과 특정 질병이나 생리적 상태를 나타내는 분자인 단백질 바이오마커의 검출에 중요한 역할을 하고 있습니다. 예를 들어 2023년 4월 미국 국립의학도서관은 미국내 신규 유전자 검사 건수가 2021년 약 1,000건에서 2022년 약 3,000건으로 증가했다고 보고했습니다. 그 결과, 유전성 질환 증가가 단백질 시퀀싱 시장의 성장을 촉진하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Protein sequencing involves deciphering the specific sequence of amino acids within a protein or peptide, which is essential for comprehending its structure and function in biomedical research.

The primary offerings in protein sequencing encompass both products and services. Protein sequencing products comprise tools and materials utilized in the determination of amino acid sequences in proteins. These products find applications in various fields such as bio-therapeutics, genetic engineering, among others, catering to end-users including pharmaceutical and biotechnology companies. Additionally, protein sequencing services provide specialized expertise and support in performing protein sequencing analyses for research and development purposes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The protein sequencing market research report is one of a series of new reports from The Business Research Company that provides protein sequencing market statistics, including protein sequencing industry global market size, regional shares, competitors with protein sequencing market share, detailed protein sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the protein sequencing industry. This protein sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The protein sequencing market size has grown rapidly in recent years. It will grow from $1.7 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to research demand, medical diagnostics, pharmaceutical development, agricultural applications, forensic analysis, biomarker discovery, and genetic evolution studies.

The protein sequencing market size is expected to see strong growth in the next few years. It will grow to $2.67 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to clinical genomics integration, expanded agricultural genomics, drug safety and pharmacogenomics, prenatal and newborn screening, and environmental DNA analysis. Major trends in the forecast period include growing demand for next-generation sequencing, increasing applications in clinical diagnostics, and rising investments in genomics research, expanding use in personalized medicine.

The forecast of 9.3% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. precision medicine efforts by inflating prices of mass spectrometry reagents and next-gen protein sequencers developed in Sweden and the UK, resulting in slower disease profiling and higher genomic research budgets. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of genetic illnesses is expected to drive the growth of the protein sequencing market. Genetic illnesses are diseases or disorders caused by abnormalities or mutations in an individual's genetic material, typically DNA. These mutations can either occur spontaneously or be inherited from parents. Protein sequencing plays a crucial role in identifying genetic variants responsible for these diseases and in detecting protein biomarkers, which are molecules that indicate a specific disease or physiological condition. For example, in April 2023, the United States National Library of Medicine reported that the number of new genetic tests in the U.S. increased from around 1,000 tests in 2021 to approximately 3,000 tests in 2022. As a result, the rise in genetic illnesses is fueling the growth of the protein sequencing market.

Leading companies in the protein sequencing market are innovating with advanced technology products, particularly upgraded sequencing kits, to maintain a competitive edge. Sequencing kits, comprising reagents, chemicals, and materials necessary for sample preparation and sequencing experiments, are continually evolving to meet the demands of the market. For instance, Quantum-Si unveiled its Protein Sequencing Kit V2 in February 2024, an enhancement for its Platinum protein sequencing platform. This upgrade offers improved sequencing performance, incorporating assay enhancements such as a new amino acid recognizer and advanced analytical and inference tools for identifying unknown proteins. These advancements not only enhance sequencing performance and reproducibility but also enable the identification of unknown proteins, accompanied by a significant reduction in cost per amino acid.

In October 2023, Thermo Fisher Scientific bolstered its presence in the proteomics market through the acquisition of Olink Holding AB for $3.1 billion. This strategic move is poised to augment Thermo Fisher's capabilities in the high-growth proteomics market, complementing its existing life sciences and mass spectrometry offerings. Olink Holding AB, based in Sweden, is dedicated to accelerating proteomics research across multiple disease areas, fostering collaborations with the scientific community to drive new discoveries and improve patient outcomes. This acquisition underscores Thermo Fisher's commitment to advancing proteomics and underscores the market's potential for growth.

Major companies operating in the protein sequencing market are F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific SE, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., BGI Group, LGC Limited, GenScript Biotech Corporation, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences Inc., Source BioScience plc, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty Ltd., SciGenom Labs Pvt Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies Inc., CeMIA SA

North America was the largest region in the protein sequencing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the protein sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the protein sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The protein sequencing market consists of revenues earned by providing services such as N-terminal protein sequencing, de novo amino acid sequencing, peptide mapping, de novo antibody sequencing, and amino acid analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein sequencing also includes sales of mass spectrometry instruments and Edman degradation sequencers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Protein Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on protein sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for protein sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The protein sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Protein Sequencing Market Characteristics

3. Protein Sequencing Market Trends And Strategies

4. Protein Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Protein Sequencing Growth Analysis And Strategic Analysis Framework

6. Protein Sequencing Market Segmentation

7. Protein Sequencing Market Regional And Country Analysis

8. Asia-Pacific Protein Sequencing Market

9. China Protein Sequencing Market

10. India Protein Sequencing Market

11. Japan Protein Sequencing Market

12. Australia Protein Sequencing Market

13. Indonesia Protein Sequencing Market

14. South Korea Protein Sequencing Market

15. Western Europe Protein Sequencing Market

16. UK Protein Sequencing Market

17. Germany Protein Sequencing Market

18. France Protein Sequencing Market

19. Italy Protein Sequencing Market

20. Spain Protein Sequencing Market

21. Eastern Europe Protein Sequencing Market

22. Russia Protein Sequencing Market

23. North America Protein Sequencing Market

24. USA Protein Sequencing Market

25. Canada Protein Sequencing Market

26. South America Protein Sequencing Market

27. Brazil Protein Sequencing Market

28. Middle East Protein Sequencing Market

29. Africa Protein Sequencing Market

30. Protein Sequencing Market Competitive Landscape And Company Profiles

31. Protein Sequencing Market Other Major And Innovative Companies

32. Global Protein Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Protein Sequencing Market

34. Recent Developments In The Protein Sequencing Market

35. Protein Sequencing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기